-+ 0.00%
-+ 0.00%
-+ 0.00%

Press Release: Organon Acquires TOFIDENCE(TM) (tocilizumab-bavi), a Commercialized Biosimilar to ACTEMRA(R) (tocilizumab) Injection, for Intravenous Infusion in the U.S.

Dow Jones·04/01/2025 11:30:00

Please log in to view news